文献速递耳科与耳神经

CSNK1A1介导LPS诱导小鼠内耳炎症与内淋巴积水

CSNK1A1 Mediates Inner Ear Inflammation and Endolymphatic Hydrops in a Lipopolysaccharide-Induced Mouse Model.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-07-03

本研究在脂多糖(LPS)诱导的内淋巴积水(EH)小鼠模型中,发现CSNK1A1在耳蜗及前庭毛细胞表达上调。腹腔注射CSNK1A1抑制剂CSNK1-IN-2可改善听前庭功能、减轻EH并减少巨噬细胞浸润,提示抑制CSNK1A1可能减轻炎症相关耳蜗前庭损伤。

要点

  • LPS诱导EH小鼠耳蜗和前庭毛细胞CSNK1A1表达显著上调。
  • CSNK1A1抑制剂CSNK1-IN-2改善ABR阈值和VEMP潜伏期。
  • 抑制CSNK1A1减轻EH并减少CD45+和F4/80+巨噬细胞浸润。

核心结论

  • CSNK1A1参与LPS诱导的内耳损伤,抑制CSNK1A1可能减轻炎症相关耳蜗前庭损伤。

研究设计与样本

  • 实验动物研究,在转译研究实验室进行,采用耳后注射LPS诱导小鼠EH模型。
  • 小鼠接受腹腔注射CSNK1A1抑制剂CSNK1-IN-2进行功能干预。

主要发现

  • LPS诱导EH小鼠耳蜗和前庭毛细胞CSNK1A1表达显著上调。
  • 抑制CSNK1A1降低所有频率ABR阈值(P < .01)。
  • 抑制CSNK1A1减轻VEMP潜伏期延长(P < .0001)。
  • 抑制CSNK1A1降低膜长度增加率(P < .01)。
  • 抑制CSNK1A1减少耳蜗和前庭CD45+及F4/80+炎症巨噬细胞浸润(P < .05)。

临床怎么用

  • CSNK1A1抑制可能作为减轻炎症相关耳蜗前庭损伤的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our previous studies demonstrated that casein kinase 1α1 (CSNK1A1) was significantly upregulated in the endolymphatic sac of patients with Meniere's disease (MD). However, its specific role in the development of MD remains unclear. This study aims to investigate the effects of CSNK1A1 inhibition on alleviating hydrops, inflammation, and preserving audiovestibular function in a mouse model of endolymphatic hydrops (EH). STUDY DESIGN: Experimental animal study. SETTING: Translational research laboratory. METHODS: An EH model was induced in mice by postauricular lipopolysaccharide (LPS) injection. CSNK1A1 localization in hair cells was visualized via immunofluorescence. To functionally interrogate CSNK1A1, mice received intraperitoneal injections of the CSNK1A1 inhibitor CSNK1-IN-2. Evaluations encompassed three key parameters: cochlear morphology (EH severity), auditory brainstem response (ABR) and vestibular evoked myogenic potential (VEMP, audiovestibular function), and immunofluorescence for CD45 and F4/80 (macrophage infiltration). RESULTS: In LPS-induced EH mice, CSNK1A1 expression was significantly upregulated in cochlear and vestibular hair cells. Pharmacological inhibition of CSNK1A1 markedly improved audiovestibular function, reducing ABR thresholds (all frequencies, P < .01) and attenuating VEMP latency prolongations (P < .0001), CSNK1A1 inhibition also reduced EH, decreasing the membrane length increase rate (P < .01), and decreased the infiltration of CD45+ and F4/80+ inflammatory macrophages in the cochlea and vestibule (P < .05). CONCLUSION: CSNK1A1 plays a role in attenuating LPS-induced inner ear injury, suggesting that its inhibition may represent a potential strategy for attenuating inflammation-associated cochleovestibular damage.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Deng W, Lai L, Li Z, et al. CSNK1A1 Mediates Inner Ear Inflammation and Endolymphatic Hydrops in a Lipopolysaccharide-Induced Mouse Model. Otolaryngol Head Neck Surg. 2026. PMID: 42398501. doi:10.1002/ohn.70334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。